Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Resonate Blends, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Revenue
0.32
0.46
0.94
1.07
1.05
0.03
0.05
0.02
1.9
Cost of revenue
0.12
0.1
0.32
0.31
0.39
0.02
0.03
0.11
0.66
Gross profit
0.2
0.36
0.63
0.75
0.66
0.01
0.02
-0.1
1.24
Research and development
0.06
Selling, general and administrative
3.21
1.18
0.11
0.13
0.18
General and administrative
0.07
0.68
0.16
0.21
0.19
1.2
Operating expenses
3.21
1.27
7.18
1.06
3.18
1.81
2.54
1.41
0.3
2.93
Operating income
-3.01
-0.91
-6.55
-0.31
-3.18
-1.81
-2.53
-1.39
-0.4
-1.7
Interest expense
0.08
0.05
Interest income
0
Other non-operating income
-0.55
-2.43
-1.1
-0.03
-0.32
-0.14
-2.34
2.04
-1.02
-0.44
Income from continuing operations
-3.51
-1.96
-4.87
0.65
Net income
-3.55
-3.32
-7.65
-0.34
-3.67
-1.94
-4.87
0.65
-1.42
-2.13
EBITDA
-3.01
-0.91
-6.55
-0.31
-2.53
-1.38
-0.39
-1.68
EPS, basic
-38.11
-19.06
-3.22
-0.06
-0.25
-0.08
-0.16
0.01
-0.02
-0.02
EPS, diluted
-38.11
-19.06
-3.22
-0.06
-0.25
-0.08
-0.19
0.01
-0.02
-0.02
Shares, basic (weighted)
0.09
174
2.64
5.58
14.1
25.5
31.1
75.4
80
98.1
Shares, diluted (weighted)
0.09
0.17
2.37
5.58
14.1
25.5
31.1
75.4
80
98.1
Balance sheet
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Cash and equivalents
0.06
0.01
0.07
0
0.11
0.01
0.06
0.01
0.01
Receivables
0
0
0
0.01
0.05
0.05
Inventory
0.25
0.16
Other current assets
0.05
0.01
Total current assets
0.06
0
0.01
0.08
0.11
0.17
0.27
0.37
0.98
1.03
Property, plant and equipment
0
0
0.03
0.02
0.02
0.02
Other non-current assets
0
0.81
Total assets
0.07
0.46
0.51
0.53
0.13
0.17
0.3
0.4
0.99
1.85
Accounts payable
0.18
0.29
0.48
0.23
0.06
0.2
0.21
0.32
0.45
1.2
Total current liabilities
1.17
1.7
0.98
0.62
0.72
1.17
4.4
1.55
3.13
5.05
Total liabilities
1.17
1.7
0.98
0.62
0.72
1.17
4.4
1.55
3.13
5.05
Paid-in capital
3.06
6.26
14.7
15.4
18.6
20.1
21.9
24.4
24.9
25.5
Retained earnings
-4.18
-7.5
-15.2
-15.5
-19.2
-21.1
-26
-25.3
-26.7
-28.9
Shareholders' equity
-1.1
-1.24
-0.47
-0.08
-0.59
-1
-4.1
-1.15
-2.14
-3.2
Total equity
-1.1
-1.24
-0.47
-0.08
-0.59
-1
-4.1
-1.15
-2.14
-3.2
Total liabilities and equity
0.07
0.46
0.51
0.53
0.13
0.17
0.3
0.4
0.99
1.85
Shares outstanding
0.21
0.26
3.22
3.22
21.4
29.8
45
75.4
86.6
110
Cash flow statement
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Net income
-3.55
-3.32
-7.65
-0.34
-3.67
-1.94
-5.76
0.65
-1.42
-2.13
Depreciation and amortization
0
0
0
0
0
0.01
0.01
0.02
Stock-based compensation
2.75
0.48
6.12
2.65
0.34
0.4
0.21
0.39
Change in receivables
0
-0
0
-0.01
-0.04
Change in inventory
-0.19
0.09
0.16
Change in payables
0.14
0.3
0.22
-0.14
-0.45
-0.01
0.11
0.46
0.75
Cash from operations
-0.38
-0.43
-0.15
-0.05
-0.79
-1.38
-2.78
-1.43
0.01
-1.03
Capital expenditures
0.02
-0.05
-0
-0
-0
-0.04
-0
-0
-0
Purchases of investments
-0.03
-0.81
-0.36
Cash from investing
0.02
-0.05
-0.03
-0.04
-0.81
-0.36
Stock issued
0.01
Cash from financing
0.44
0.35
0.2
0.11
0.82
1.49
2.72
1.48
0.74
1.39
Net change in cash
0.06
-0.06
0.01
0.06
0
0.11
-0.1
0.05
-0.06
0
Free cash flow
-0.41
-0.19
-0.06
-0.79
-1.38
-2.82
-1.43
0.01
-1.03
Interest paid
0
0.01
0.01
0.01
0.04
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2025; growth uses fiscal years. Valuation uses the share price of $0.00 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
65.5%
Gross profit / revenue.
Operating margin
-72.2%
Operating income / revenue.
Net margin
51.2%
Net income / revenue.
FCF margin
-47.8%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-47.8%
Cash from operations / revenue.
Return on assets (ROA)
95.1%
Net income / average total assets.
Capex / revenue
0.0%
Capital expenditures / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
11,415.0%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
312.4%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
12.5%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit CAGR, 3y
439.3%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
13.5%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y
-9,316.0%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
-10,232.0%
Free cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
86.9%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
83.3%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
69.9%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
22.6%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
46.7%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
47.5%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.22x
Current assets / current liabilities.
Quick ratio
0.01x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.00x
(Cash + short-term investments) / current liabilities.
Free cash flow / net income, when net income is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$0.01
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.01
Revenue / diluted weighted shares.
FCF per share
-$0.01
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.01
Cash from operations / diluted weighted shares.
Book value per share
-$0.02
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
0.05x
Market cap / net income. Only when net income is positive.
P/S
0.03x
Market cap / revenue.
EV/Sales
0.02x
Enterprise value / revenue.
FCF yield
-1,821.0%
Free cash flow / market cap.
Earnings yield
1,952.0%
Net income / market cap (the inverse of P/E).
What was Resonate Blends, Inc.'s revenue in fiscal 2024?
Resonate Blends, Inc. reported revenue of $1.9M for fiscal 2024, 11,414.5% higher than the year before.
Was Resonate Blends, Inc. profitable in fiscal 2024?
No. It reported a net loss of $2.1M.
How much free cash flow did Resonate Blends, Inc. generate in fiscal 2024?
Cash from operations of $1.0M minus capital expenditures of $1.0K left free cash flow of -$1.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.